Acute lymphocytic leukemia
Researchers at the University of California San Diego (UCSD) conducted a retrospective study to evaluate seizure outcomes and identify predisposing factors for epilepsy in patients diagnosed with B-cell acute lymphoblastic leukemia (B-ALL). The study involved 23 patients who met the inclusion criteria, with a mean age at B-ALL diagnosis of
Pediatrics
A new study has shed light on the incidence of hyperglycemia in pediatric acute lymphoblastic leukemia (ALL) patients during induction therapy. The research, conducted at a single tertiary care center in Cairo, Egypt, analyzed 1711 pediatric ALL patients treated between 2016 and 2019. The study found that hyperglycemia occurred in
Pediatrics
Researchers at Chang Gung University have conducted a study on the relationship between urine output and time to methotrexate clearance in pediatric leukemia patients receiving high-dose methotrexate therapy. The study found that patients with higher urine output showed significantly faster methotrexate clearance, lower incidence of delayed clearance, and shorter hospital
Pediatrics
Researchers at the University of Basrah have conducted a comparative analysis of immaturity CD markers in acute lymphoblastic leukemia (ALL) among children and adults, highlighting significant variations in marker expression between the two groups. The study, published in Acta Medica, aimed to assess the expression levels of CD34, HLA-DR, TdT,
Pediatrics
Research published in Pediatric Blood & Cancer has identified a significant association between visceral fat area and body fat mass with an increased risk of methotrexate toxicity in pediatric patients with acute lymphoblastic leukemia and lymphoblastic lymphoma. The study, conducted by researchers at the Nacional Institute of Pediatrics, found that
Pediatrics
Recent research has shed new light on the role of prednisone response in pediatric acute lymphoblastic leukemia (ALL). A study published in the Annals of Hematology has demonstrated that while prednisone response (PR) remains a key early treatment indicator, its independent prognostic significance has decreased with the advent of minimal
Pediatrics
A recent study published in Pediatric Blood & Cancer has shed light on the relationship between visceral fat and body fat mass as risk factors for methotrexate toxicity in pediatric acute lymphoblastic leukemia and lymphoblastic lymphoma. Researchers at the Nacional Institute of Pediatrics in Mexico City, Mexico, analyzed the body
Pediatrics
Researchers have conducted a comprehensive study to assess the expression levels of different immaturity CD markers in subtypes of Acute Lymphoblastic Leukemia (ALL) among children and adults. The dataset included CD marker expressions for 130 ALL patients, comprising 51 pediatric B-ALL, 16 pediatric T-ALL, 44 adult B-ALL, and 19 adult
Pediatrics
Current study results on Oncology - Acute Lymphoblastic Leukemia have been published, highlighting the importance of urine output in methotrexate clearance in pediatric patients. Researchers conducted a retrospective study of 39 patients treated with high-dose methotrexate at Chang Gung Memorial Hospital, finding that higher urine output was associated with faster
Pediatrics
Current study results on pediatric acute lymphoblastic leukemia (ALL) have been published, focusing on the prognostic value of prednisone response. The study, conducted by investigators at the First Affiliated Hospital of Guangxi Medical University, analyzed clinical data from 2,979 pediatric patients primarily diagnosed with ALL. The results showed that
Pediatrics
New research has shed light on the impact of genomics in an individual cohort of adolescents and young adults (AYA) patients with acute lymphoblastic leukemia (ALL) treated on a single protocol. The study, conducted by researchers at the South Australian Health and Medical Research Institute, aimed to describe the genomic
Pediatrics
A recent study from the UiT The Arctic University of Norway has assessed growth patterns in a national cohort of children aged 0-17.9 years diagnosed with acute lymphoblastic leukemia (ALL). The research findings, published in Acta Paediatrica, reveal significant fluctuations in weight and height growth during treatment and remission.
